Members

  First name: Aurélien
  Last name: Marc
  Position: PhD student
  Email: aurelien.marc
._
_.
inserm.fr

Research interest


PhD subject : Modelling the impact of antivirals treatments in SARS-CoV-2 infected individuals.

Education

Degree

2019: M.D. in System biology, Paris 6 University

Academic positions

2019-present: PhD student in mathematical modelling of emerging diseases.

List of the main publications

Marc A, Kerioui M, Blanquart F, Bertrand J, Mitjà O, Corbacho-Monné M, Marks M, Guedj J
Quantifying the relationship between SARS-CoV-2 viral load and infectiousness.
eLife 2021, 10, e69302.


Exhaustive list of publications

2023


Suñer C, Ubals M, Tarín-Vicente EJ, Mendoza A, Alemany A, Hernández-Rodríguez Á, Casañ C, Descalzo V, Ouchi D, Marc A, Rivero À, Coll P, Oller X, Miguel Cabrera J, Vall-Mayans M, Dolores Folgueira M, Ángeles Melendez M, Agud-Dios M, Gil-Cruz E, Paris de Leon A, Ramírez Marinero A, Buhiichyk V, Galván-Casas C, Paredes R, Prat N, Sala Farre MR, Bonet-Simó JM, Farré M, Ortiz-Romero PL, Clotet B, García-Patos V, Casabona J, Guedj J, Cardona PJ, Blanco I, Movie Group, Marks M, Mitjà O
Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain.
The Lancet. Infectious Diseases 2023, 23, 445-453.

Nguyen BT, Marc A, Suñer C, Marks M, Ubals M, Hernández-Rodríguez Á, Melendez MÁ, Movie Group, Hruby DE, Russo AT, Mentré F, Mitjà O, Grosenbach DW, Guedj J
Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection.
PLoS biology 2023, 21, e3002249.

Marc A, Marlin R, Donati F, Prague M, Kerioui M, Hérate C, Alexandre M, Dereuddre-Bosquet N, Bertrand J, Contreras V, Behillil S, Maisonnasse P, Van Der Werf S, Le Grand R, Guedj J
Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.
PLoS computational biology 2023, 19, e1010721.

2021


Maisonnasse P, Aldon Y, Marc A, Marlin R, Dereuddre-Bosquet N, Kuzmina NA, Freyn AW, Snitselaar JL, Gonçalves A, Caniels TG, Burger JA, Poniman M, Bontjer I, Chesnais V, Diry S, Iershov A, Ronk AJ, Jangra S, Rathnasinghe R, Brouwer PJM, Bijl TPL, van Schooten J, Brinkkemper M, Liu H, Yuan M, Mire CE, van Breemen MJ, Contreras V, Naninck T, Lemaître J, Kahlaoui N, Relouzat F, Chapon C, Ho Tsong Fang R, McDanal C, Osei-Twum M, St-Amant N, Gagnon L, Montefiori DC, Wilson IA, Ginoux E, de Bree GJ, García-Sastre A, Schotsaert M, Coughlan L, Bukreyev A, van der Werf S, Guedj J, Sanders RW, van Gils MJ, Le Grand R
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.
Nature Communications 2021, 12, 6097.

Marc A, Kerioui M, Blanquart F, Bertrand J, Mitjà O, Corbacho-Monné M, Marks M, Guedj J
Quantifying the relationship between SARS-CoV-2 viral load and infectiousness.
eLife 2021, 10, e69302.